DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Employees78,000IPOApr 28, 2025SIC8092HQ2000 16th Street, Denver, CO, USA, 80202
to
Financials (EUR)
Profitability
Metric
Current
Margins
Gross Margin
32.3%
Operating Margin
14.7%
EBITDA Margin
19.4%
Net Margin
5.5%
OCF Margin
—
FCF Margin
9.4%
Returns on Capital
ROE
—
ROA
4.3%
ROIC
9.9%
ROCE
13.4%
ROC (Greenblatt)
34.9%
3Y ROIIC
−149.2%
Consistency
Years Profitable / 10Y
10
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
15.13
Forward P/E
11.30
P/E ex-NRI
13.81
Shiller P/E (CAPE)
20.88
Cash Flow Multiples
P/FCF
8.43
P/OCF
5.90
P/Owner Earnings
13.35
FCF Yield
13.08%
Enterprise Value Multiples
EV / EBIT
12.46
EV / Forward EBIT
10.38
EV / EBITDA
9.09
EV / Forward EBITDA
7.73
EV / Revenue
1.76
EV / Forward Revenue
1.58
Asset / Sales
P/S
0.83
P/B
—
P/Tangible Book
—
Growth-Adjusted
PEG
1.05
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
0.00%
Forward Dividend Yield
0.00%
3Y Dividend Growth
0.0%
Payout Ratio
0.00
5Y Yield on Cost
0.00%
Buybacks & Dilution
3Y Buyback Ratio
8.80%
5Y Share Change
−38.2%
Combined
Shareholder Yield
10.39%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
−19.77
Gross Debt / EBITDA
4.87
Cash / Debt
0.05
Equity / Assets
−0.04
Coverage
Interest Coverage
3.47
Short-Term Liquidity
Current Ratio
1.29
Quick Ratio
1.24
Cash Ratio
0.22
Composite Scores
Piotroski F-Score
6
Altman Z-Score
1.55
Split History
Date
Split
No split history found.
Ex-date
Amount
Pay date
No dividend history found.
Date
Transcript
Type
2026-08-04
Q2 2026 DaVita Inc Earnings Call Transcript
Earnings Call
2026-05-05
Q1 2026 DaVita Inc Earnings Call Transcript
Earnings Call
2026-03-02
DaVita Inc at TD Cowen Healthcare Conference Transcript
Conference Presentations
2026-02-02
Q4 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-10-29
Q3 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-08-05
Q2 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-05-12
Q1 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-02-13
Q4 2024 DaVita Inc Earnings Call Transcript
Earnings Call
2024-10-29
Q3 2024 DaVita Inc Earnings Call Transcript
Earnings Call
2024-08-06
Q2 2024 DaVita Inc Earnings Call Transcript
Earnings Call
10 of 40
5-Step DuPont Analysis
ROE %
-296.36%
×
×
Net Margin %
5.47%
×
×
Operating Margin %
14.72%
Operating Income
€1.75B
÷
Revenue
€11.92B
×
Tax Burden
0.5549
Net Income
€652M
÷
Pretax Income
€1.18B
×
Interest Burden
0.6699
Pretax Income
€1.18B
÷
Operating Income
€1.75B
×
Asset Turnover
0.76
÷
Revenue
€11.92B
÷
Average Total Assets
€15.72B
Begin Total Assets
€16.51B
End Total Assets
€14.93B
×
Equity Multiplier
-71.44
÷
Avg Total Assets
€15.72B
÷
Avg Stockholders Equity
−€220M
Begin Equity
€116M
End Equity
−€556M